Flu News and Research

RSS

St. Jude scientists develop insights to guide development of powerful novel anti-influenza drugs

By analyzing the molecular details of how artificially created drug-resistant flu strains manage to survive treatment, St. Jude Children's Research Hospital scientists have developed insights to guide development of powerful new anti-influenza drugs. These compounds will target a viral enzyme critical to the virus' proliferation in the body.

15 Mar 2016

NIH-funded investigators develop therapeutic compound effective against malaria

An international team that includes NIH-funded researchers at Stanford University has developed a therapeutic compound that is effective in inhibiting Plasmodium falciparum, one of five species of parasite that infects people with malaria, and the strain which causes the highest number of malaria deaths.

13 Mar 2016

Maternal Immunations app aims to guide, remind pregnant women about vaccines

A new app to guide and remind pregnant women about vaccines recommended during pregnancy has been launched by researchers

11 Mar 2016

Vanderbilt investigators isolate human antibodies against H7 bird flu

Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.

10 Mar 2016

Rutgers' new drug candidate may help fight malaria

Malaria killed about 440,000 people - mostly young children - last year, but a new drug candidate discovered at Rutgers may help fight the long-dreaded disease.

8 Mar 2016

State laws increase vaccination rates among health care workers

State laws mandating influenza immunization for people who work in health care increase their vaccination rates, according to new research led by the University of Pittsburgh School of Medicine.

3 Mar 2016

Poll: 59% of parents rate flu vaccine less favorably than other childhood vaccines

Parents who do not get their children flu shots rate the flu vaccine less favorably than other childhood vaccines, a national poll finds.

23 Feb 2016

Research proposes new contract scheme for flu vaccine distribution

Research co-authored by Fuqiang Zhang, professor of operations and manufacturing management at Washington University in St. Louis' Olin Business School, proposes a new contract scheme for the vaccine supply chain that could reduce patient wait time.

19 Feb 2016

Rehabilitation-induced reorganization of damaged brain circuits responsible for functional recovery

Each year millions of people worldwide suffer from stroke, which can occur to anyone at any time. While some may recover completely, the majority of survivors will experience some form of impairment that requires a lengthy process toward partial or full recovery of functioning. Therefore, continuous improvement of rehabilitation methods is needed to ensure more positive long-term outcomes among survivors.

19 Feb 2016

BiondVax gains additional support from NATI for ongoing development of Universal Flu Vaccine

BiondVax Pharmaceuticals Ltd. announced today that the National Authority for Technological Innovation, formerly known as the Office of the Chief Scientist, agreed to fund up to 40% of a NIS 3.6 million (US$920,000) project towards ongoing development of the Company's Universal Flu Vaccine.

18 Feb 2016

Specialised white blood cell in birds can destroy fatal fungal infection

Scientists have discovered that a specialised white blood cell found in birds can destroy a potentially fatal fungal infection which affects more than one million people every year.

18 Feb 2016

Co-parenting a child has bigger impact on the immune system than flu vaccine or gastroenteritis

Raising a child together has a greater effect on your immune system than the seasonal 'flu vaccine or travellers' gastroenteritis, a study by researchers at VIB and KU Leuven in Belgium and the Babraham Institute in the UK has found.

16 Feb 2016

Most stage III melanoma patients do not benefit from interferon treatment

Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment with interferon.

15 Feb 2016

Protein Sciences, UNIGEN agree to supply Flublok influenza vaccine for the U.S. market from Japan

Protein Sciences Corporation (Meriden, CT and Pearl River, NY) and UMN Pharma Inc. (Akita, Akita prefecture, Japan) announced today that Protein Sciences and UNIGEN Inc., a joint venture of UMN and IHI Corporation (Koto-ku, Tokyo, Japan), entered into an agreement to source bulk Flublok influenza vaccine from Japan for the U.S. market.

12 Feb 2016

Leeds scientists to start computer drug research to find cure for Ebola virus

Scientists at the University of Leeds will run the equivalent of password cracking software to find the chemical keys to defeating the Ebola virus.

11 Feb 2016

UW-Madison research team starts work on Zika virus infection

In October, when David O'Connor last visited Brazil as part of a decade-long research program studying drug-resistant strains of HIV, one of his Brazilian collaborators had a request.

11 Feb 2016

First case of Zika virus found in Ohio

"This is not unexpected," says Frank Esper, MD, infectious disease specialist at University Hospitals Rainbow Babies & Children's Hospital in Cleveland, after learning of the first case of Zika virus in Ohio, found in a Cleveland woman who traveled to Haiti. "We know people are going to come back and they're going to have the Zika virus."

11 Feb 2016

Cold viruses at school largely to blame for asthma hospitalizations

The most dangerous times of year for children with asthma are soon after their schools reopen after a break, and a new study finds that cold viruses are largely to blame.

9 Feb 2016

Gut microbes influence severity of malaria

Microorganisms in the gut could play a role in reducing the severity of malaria, according to a new study co-authored by researchers at the University of Tennessee, Knoxville, and the University of Louisville.

9 Feb 2016

Early use of influenza drug in pregnant women with flu may reduce length of stay in hospital

Pregnant women are at higher risk for serious illness and complications, including death, from influenza. For expectant mothers hospitalized with flu, early treatment with the influenza antiviral drug oseltamivir may shorten their time in the hospital, especially in severe cases, suggests a new study published in The Journal of Infectious Diseases and available online.

5 Feb 2016

Flu News and Research

St. Jude scientists develop insights to guide development of powerful novel anti-influenza drugs

NIH-funded investigators develop therapeutic compound effective against malaria

Maternal Immunations app aims to guide, remind pregnant women about vaccines

Vanderbilt investigators isolate human antibodies against H7 bird flu

Rutgers' new drug candidate may help fight malaria

State laws increase vaccination rates among health care workers

Poll: 59% of parents rate flu vaccine less favorably than other childhood vaccines

Research proposes new contract scheme for flu vaccine distribution

Rehabilitation-induced reorganization of damaged brain circuits responsible for functional recovery

BiondVax gains additional support from NATI for ongoing development of Universal Flu Vaccine

Specialised white blood cell in birds can destroy fatal fungal infection

Co-parenting a child has bigger impact on the immune system than flu vaccine or gastroenteritis

Most stage III melanoma patients do not benefit from interferon treatment

Protein Sciences, UNIGEN agree to supply Flublok influenza vaccine for the U.S. market from Japan

Leeds scientists to start computer drug research to find cure for Ebola virus

UW-Madison research team starts work on Zika virus infection

First case of Zika virus found in Ohio

Cold viruses at school largely to blame for asthma hospitalizations

Gut microbes influence severity of malaria

Early use of influenza drug in pregnant women with flu may reduce length of stay in hospital

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News